Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors
- PMID: 1654205
Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors
Abstract
In the accompanying paper (K. Tanabe, Y. Ikegami, R. Ishida, and T. Andoh, Cancer Res., 51: 4903-4908, 1991), we showed that ICRF-154 and -193, dioxopiperazine derivatives, inhibited the activity of purified topoisomerase II, without formation of a cleavable DNA-protein complex. In order to see whether ICRF-154 and ICRF-193 affect cellular topoisomerase II in situ or not, we examined the effect of these drugs on etoposide (VP-16)-induced, topoisomerase II-mediated DNA breaks in RPMI 8402 cells by alkaline sedimentation analysis. When RPMI 8402 cells were exposed to VP-16 in the presence of ICRF-154 or ICRF-193 for 1 h, VP-16-induced DNA strand breaks were greatly inhibited by both ICRF compounds. In parallel with this observation, VP-16-induced growth inhibition was also reversed by ICRF-193. Exposure of cells to ICRF-154 resulted in a progressive accumulation of cells with 4C DNA content. Although mitotic index did not significantly increase, mitotic abnormalities were seen in cells exposed to ICRF-193 or ICRF-154: all mitotic cells exhibited early mitotic figures with fewer condensed and entangled chromosomes. The most sensitive phase of the cell cycle to ICRF-154 was the G2-M. ICRF-154 did not affect the spindle formation. However, abnormally oriented spindles were observed in drug-treated cells in parallel with the appearance of multinucleated cells. The results suggest that ICRF-154 and -193 inhibit topoisomerase II activity in RPMI 8402 cells, and this effect resulted in the appearance of cells in G2 and early M phase with fewer condensed and entangled chromosomes and of cells with multilobed nuclei.
Similar articles
-
Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.Cancer Res. 1991 Sep 15;51(18):4903-8. Cancer Res. 1991. PMID: 1654204
-
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.Cancer Res. 1998 Apr 1;58(7):1460-8. Cancer Res. 1998. PMID: 9537249
-
Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.Mol Pharmacol. 2000 Feb;57(2):296-307. Mol Pharmacol. 2000. PMID: 10648639
-
Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.Adv Pharmacol Chemother. 1982;19:249-90. doi: 10.1016/s1054-3589(08)60025-3. Adv Pharmacol Chemother. 1982. PMID: 6819768 Review. No abstract available.
-
Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardioprotectors and antitumor drugs.Biochimie. 1998 Mar;80(3):235-46. doi: 10.1016/s0300-9084(98)80006-0. Biochimie. 1998. PMID: 9615863 Review.
Cited by
-
Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone.Eur J Med Chem. 2019 Jun 15;172:109-130. doi: 10.1016/j.ejmech.2019.03.040. Epub 2019 Mar 20. Eur J Med Chem. 2019. PMID: 30959322 Free PMC article.
-
The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation.Nucleic Acids Res. 2008 Oct;36(18):5822-31. doi: 10.1093/nar/gkn560. Epub 2008 Sep 12. Nucleic Acids Res. 2008. PMID: 18790802 Free PMC article.
-
Acidic pH induces topoisomerase II-mediated DNA damage.Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5205-10. doi: 10.1073/pnas.0935978100. Epub 2003 Apr 11. Proc Natl Acad Sci U S A. 2003. PMID: 12692309 Free PMC article.
-
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview.Int J Mol Sci. 2020 Jul 12;21(14):4919. doi: 10.3390/ijms21144919. Int J Mol Sci. 2020. PMID: 32664667 Free PMC article. Review.
-
Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression.Mol Cell Biol. 2009 Nov;29(21):5911-22. doi: 10.1128/MCB.00558-09. Epub 2009 Aug 24. Mol Cell Biol. 2009. PMID: 19704007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous